前收市價 | 7,727.42 |
開市 | 7,727.42 |
成交量 |
今日波幅 | 7,714.90 - 7,750.17 |
52 週波幅 | 7,215.80 - 7,936.10 |
平均成交量 | 1,005,487,691 |
European stocks drifted higher on Monday in line with equities globally amid upbeat sentiment to start a week dominated by news out of central banks. Frankfurt’s DAX advanced 0.3% with the pan-European Stoxx 600 gaining 0.1%. A big week for central banks lies ahead, with the Bank of Japan widely expected to raise interest rates into positive territory for the first time in almost a decade on Tuesday and a rate decision from the Federal Reserve due on Wednesday.
LONDON (Reuters) -Reckitt said on Monday that many cases had been filed against baby formula makers in general, and it was unclear how many directly related to its unit's Enfamil product. An Illinois jury last week ordered Reckitt unit Mead Johnson to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed the company's Enfamil baby formula. The jury in a state court in St. Clair County found Mead Johnson was negligent and had failed to warn of the risk of necrotising enterocolitis (NEC).
London-listed shares of the consumer goods giant dropped more than 15% to their lowest in a decade, as the verdict triggered fears that Reckitt would face more financial liabilities from lawsuits related to the baby formula. An Illinois jury ordered Reckitt unit Mead Johnson on Wednesday to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed Enfamil. "We strongly disagree with the jury's decision to fault Mead Johnson and award damages," Reckitt said in a statement on Friday.